Prevenar Articles
Pfizer’s Sutent fails to meet endpoint in NSCLC study; Prevenar 13 gains WHO pre-qualification
25 August 2010
Pfizer and GlaxoSmithKline pledge long-term supply of pneumococcal vaccines to world's poorest countries at big discount
24 March 2010
Showing 1-4 of 4 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
